News | December 22, 2024
Shilpa Medicare’s Unit VII, Nacharam, Hyderabad receives GMP certificate from EMA, Austria
The company has received the GMP Certification after successful closure of the inspection
The company has received the GMP Certification after successful closure of the inspection
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
The Alathur facility specializes in the production of Cephalosporin antibiotics
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Zefylti will be available as 30 MU/0.5 mL and 48 MU/0.5 mL and is intended for the treatment of neutropenia and the mobilisation of peripheral progenitor cells
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Subscribe To Our Newsletter & Stay Updated
